Novavax (NVAX) Tops Q2 EPS by 12c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Novavax (NVAX) Tops Q2 EPS by 12c, Revenues Miss

Novavax Reports Second Quarter 2020 Financial and Operational Results

August 10, 2020 4:03 PM EDT

Announced Positive Phase 1 data of Phase 1/2 clinical trial of NVX-CoV2373
Secured $2 billion in funding for global coronavirus vaccine program through CEPI, DoD, and OWSExpanded large scale global manufacturing capacity through acquisition and partneringCompany to host conference call today at 4:30 p.m. ET

GAITHERSBURG, Md., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its financial results and operational... More